December 21, 2022
Evan Dellon, MD, MPH, a professor in the Department of Medicine and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis.
November 22, 2022
Jacqueline Halladay, MD, MPH, from UNC Family Medicine, and Doyle “Skip” Cummings, PharmD, from the ECU Brody School of Medicine, are leading a five-year, $5.6 million PCORI grant to understand if a technology-enabled team-based approach results in greater blood pressure control compared to usual care in populations of people with uncontrolled high blood pressure.
November 21, 2022
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in the UNC Department of Neurosurgery and at UNC Lineberger, led the trial site at the N.C. Basnight Cancer Hospital.
November 18, 2022
Brenna Maddox, PhD, at the UNC School of Medicine, will lead a study to help autistic adults, clinicians, and other key stakeholders select which mental health intervention is the best fit for individual patients.
November 11, 2022
A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. Led by William Fischer, MD, principal investigator, and David Wohl, MD, co-lead, the study plans to enroll 7,500 COVID-positive individuals to understand the different factors that impact individual risk for key clinical outcomes including recovery from acute illness, symptom rebound, re-infection, and long COVID. Investigators explain the study more in video.
September 28, 2022
This nationwide clinical trial funded through the National Institutes of Health including participation from patients at the UNC Diabetes Center, led by John Buse, MD, PhD.
September 22, 2022
The national GRADE study, with leadership and participation from UNC School of Medicine's John Buse, MD, PhD, and Sue Kirkman, MD, found that two of four common type 2 diabetes treatments -- glargine and liraglutide -- worked better than the other drugs, sitagliptin and glimepiride, to maintain blood glucose levels.
August 31, 2022
UNC School of Medicine’s 55th annual Student Research Day will take place on Friday, Nov. 11. The John B. Graham Research Society is seeking faculty judges to help make the day a success by providing formative feedback to student presenters.
August 17, 2022
The Women’s Irritability, Stress, and Estrogen Study aims to understand the biological mechanisms underlying the relationship between estrogen changes and increased irritability during the menopause transition.
August 9, 2022
The Doris Duke Charitable Foundation awarded more than $7.9 million in grants to 16 early-career physician scientists, including two from the UNC School of Medicine – Andrea Knittel, MD, PhD and Peyton Thompson, MD.
July 27, 2022
The UNC site lead investigators are Michelle Hernandez, MD, professor in the UNC Department of Pediatrics, and Katrina Donahue, MD, MPH, professor and vice chair of research in the UNC Department of Family Medicine.
July 5, 2022
The Clinical Trials Unit in the UNC Children’s Research Institute is a site for a national study to assess the efficacy of Paxlovid, a pill to treat COVID in children under 18 at increased risk for severe illness.